Greedy Insider · Filing
PTHS · 13D amendment · Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated reported a 49.9% stake in Pelthos Therapeutics Inc. (PTHS) in a Schedule 13D amendment filed on Nov 3, 2026, triggered by an event on Oct 30, 2026.
Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001193125-26-445875